SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-192338
Filing Date
2023-07-24
Accepted
2023-07-24 17:05:00
Documents
15
Period of Report
2023-07-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d558666d8k.htm   iXBRL 8-K 29774
2 EX-5.1 d558666dex51.htm EX-5.1 8345
3 EX-10.1 d558666dex101.htm EX-10.1 198552
7 GRAPHIC g558666g0724120417415.jpg GRAPHIC 2533
  Complete submission text file 0001193125-23-192338.txt   427090

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA awh-20230720.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE awh-20230720_lab.xml EX-101.LAB 18758
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE awh-20230720_pre.xml EX-101.PRE 11716
9 EXTRACTED XBRL INSTANCE DOCUMENT d558666d8k_htm.xml XML 3577
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 231105715
SIC: 2835 In Vitro & In Vivo Diagnostic Substances